Bioequivalence Study of Oral Suspension and Intravenous Formulation of Edaravone in Healthy Adult Subjects

The neuroprotective agent edaravone is an intravenous treatment for amyotrophic lateral sclerosis. As intravenous administration burdens patients, orally administered treatments are needed. This phase 1, open‐label, single‐dose crossover study in 42 healthy adults evaluated bioequivalence of a 105‐m...

Descripción completa

Detalles Bibliográficos
Autores principales: Shimizu, Hidetoshi, Nishimura, Yukiko, Shiide, Youichi, Yoshida, Kaori, Hirai, Manabu, Matsuda, Munetomo, Nakamaru, Yoshinobu, Kato, Yuichiro, Kondo, Kazuoki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8518908/
https://www.ncbi.nlm.nih.gov/pubmed/33955162
http://dx.doi.org/10.1002/cpdd.952

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8518908/
https://www.ncbi.nlm.nih.gov/pubmed/33955162
http://dx.doi.org/10.1002/cpdd.952

Ejemplares similares